19650895

Source:http://linkedlifedata.com/resource/pubmed/id/19650895

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012963, umls-concept:C0030705, umls-concept:C0038435, umls-concept:C0205160, umls-concept:C0205217, umls-concept:C0439234, umls-concept:C0504053, umls-concept:C0559546, umls-concept:C1274040, umls-concept:C1280412
pubmed:dateCreated	2009-8-21
pubmed:abstractText	To determine if patients without dobutamine induced left ventricular wall motion abnormalities (WMA) but an increased LV end-diastolic wall thickness (EDWT) exhibit a favorable cardiac prognosis.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/M01RR07122, http://linkedlifedata.com/resource/pubmed/grant/P30AG21332, http://linkedlifedata.com/resource/pubmed/grant/R01 HL076438-05, http://linkedlifedata.com/resource/pubmed/grant/R01HL074330
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-10525488, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-10645921, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-11348601, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-11673343, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-11738323, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-12397006, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-12403662, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-12413374, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-12485966, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-12707239, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-12860897, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-15193690, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-15289384, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-15939807, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-1615867, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-16376782, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-16754804, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-17353441, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-17372030, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-2247116, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-2942070, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-510803, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-5544988, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-8025988, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-8644665, http://linkedlifedata.com/resource/pubmed/commentcorrection/19650895-9989961
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9815616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Dobutamine
pubmed:status	MEDLINE
pubmed:issn	1532-429X
pubmed:author	pubmed-author:ChughtaiHaroonH, pubmed-author:Dall'ArmellinaEricaE, pubmed-author:HamiltonCraig ACA, pubmed-author:HundleyW GregoryWG, pubmed-author:KitzmanDalane WDW, pubmed-author:LinkKerry MKM, pubmed-author:MorganTimothy MTM, pubmed-author:NtimWilliamW, pubmed-author:WalshThomas FTF
pubmed:issnType	Electronic
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	25
pubmed:dateRevised	2010-12-3
pubmed:meshHeading	pubmed-meshheading:19650895-Adrenergic beta-Agonists, pubmed-meshheading:19650895-Aged, pubmed-meshheading:19650895-Aged, 80 and over, pubmed-meshheading:19650895-Angina, Unstable, pubmed-meshheading:19650895-Cardiovascular Diseases, pubmed-meshheading:19650895-Dobutamine, pubmed-meshheading:19650895-Female, pubmed-meshheading:19650895-Heart Failure, pubmed-meshheading:19650895-Hospitalization, pubmed-meshheading:19650895-Humans, pubmed-meshheading:19650895-Kaplan-Meier Estimate, pubmed-meshheading:19650895-Magnetic Resonance Imaging, Cine, pubmed-meshheading:19650895-Male, pubmed-meshheading:19650895-Middle Aged, pubmed-meshheading:19650895-Myocardial Contraction, pubmed-meshheading:19650895-Myocardial Infarction, pubmed-meshheading:19650895-Observer Variation, pubmed-meshheading:19650895-Predictive Value of Tests, pubmed-meshheading:19650895-Prognosis, pubmed-meshheading:19650895-Proportional Hazards Models, pubmed-meshheading:19650895-Risk Assessment, pubmed-meshheading:19650895-Risk Factors, pubmed-meshheading:19650895-Stroke Volume, pubmed-meshheading:19650895-Time Factors, pubmed-meshheading:19650895-Ventricular Dysfunction, Left
pubmed:year	2009
pubmed:articleTitle	Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress.
pubmed:affiliation	Department of Internal Medicine (Cardiology Section), Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina, USA. Thomas.Walsh@jax.ufl.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural